143 related articles for article (PubMed ID: 32911601)
1. Changed Profile of Serum Transferrin Isoforms in Primary Biliary Cholangitis.
Grytczuk A; Bauer A; Gruszewska E; Cylwik B; Chrostek L
J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32911601
[TBL] [Abstract][Full Text] [Related]
2. Increased intercellular adhesion molecule-1 serum concentration in cholestasis.
Polzien F; Ramadori G
J Hepatol; 1996 Dec; 25(6):877-86. PubMed ID: 9007716
[TBL] [Abstract][Full Text] [Related]
3. Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis.
Gerussi A; Bernasconi DP; O'Donnell SE; Lammers WJ; Van Buuren H; Hirschfield G; Janssen H; Corpechot C; Reig A; Pares A; Battezzati PM; Zuin MG; Cazzagon N; Floreani A; Nevens F; Gatselis N; Dalekos G; Mayo MJ; Thorburn D; Bruns T; Mason AL; Verhelst X; Kowdley K; van der Meer A; Niro GA; Beretta-Piccoli BT; Marzioni M; Belli LS; Marra F; Valsecchi MG; Lindor KD; Invernizzi P; Hansen BE; Carbone M;
Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1688-1697.e14. PubMed ID: 32777554
[TBL] [Abstract][Full Text] [Related]
4. Transferrin isoforms analysis by capillary electrophoresis in systemic lupus erythematosus and systemic sclerosis.
Chrostek L; Gindzieńska-Sieśkiewicz E; Gruszewska E; Kowal-Bielecka O; Cylwik B
Scand J Clin Lab Invest; 2020 Nov; 80(7):567-570. PubMed ID: 32820969
[TBL] [Abstract][Full Text] [Related]
5. Changed Profile of Serum Transferrin Isoforms in Liver Diseases.
Gudowska M; Gruszewska E; Panasiuk A; Cylwik B; Swiderska M; Filisiak R; Szmitkowski M; Chrostek L
Clin Lab; 2017 Feb; 63(2):349-354. PubMed ID: 28182352
[TBL] [Abstract][Full Text] [Related]
6. Serum profile of transferrin isoforms in rheumatoid arthritis treated with biological drugs.
Cylwik B; Gruszewska E; Gindzienska-Sieskiewicz E; Kowal-Bielecka O; Chrostek L
Clin Biochem; 2019 Dec; 74():31-35. PubMed ID: 31672652
[TBL] [Abstract][Full Text] [Related]
7. Obeticholic acid for the treatment of primary biliary cholangitis.
Ali AH; Lindor KD
Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
[TBL] [Abstract][Full Text] [Related]
8. The Profile of Serum Transferrin Isoforms in Rheumatoid Arthritis.
Gudowska M; Gruszewska E; Wrona A; Gindzienska-Sieskiewicz E; Domyslawska I; Lipartowska-Klimuk K; Cylwik B; Sierakowski S; Chrostek L
J Clin Rheumatol; 2019 Jun; 25(4):159-162. PubMed ID: 29782424
[TBL] [Abstract][Full Text] [Related]
9. [The effect of Cathepsin S in primary biliary cholangitis].
Luo X; Li X; Du ZR; Peng Y; Deng CW; Fei YY
Zhonghua Yi Xue Za Zhi; 2019 Feb; 99(7):505-509. PubMed ID: 30786347
[No Abstract] [Full Text] [Related]
10. Serum profile of transferrin isoforms in juvenile idiopathic arthritis: a preliminary study.
Gruszewska E; Sienkiewicz M; Abramowicz P; Konstantynowicz J; Gudowska-Sawczuk M; Chrostek L; Cylwik B
Rheumatol Int; 2018 Jul; 38(7):1235-1240. PubMed ID: 29761223
[TBL] [Abstract][Full Text] [Related]
11. Implication of increased serum stromal cell-derived factor-1 for primary biliary cholangitis.
Yang Z; Liang Y; Lin F; Zhang Z; Luo W; Zhang Y; Zhong R
Int Immunopharmacol; 2018 Mar; 56():285-290. PubMed ID: 29414663
[TBL] [Abstract][Full Text] [Related]
12. Plasma antioxidant levels in chronic cholestatic liver diseases.
Floreani A; Baragiotta A; Martines D; Naccarato R; D'odorico A
Aliment Pharmacol Ther; 2000 Mar; 14(3):353-8. PubMed ID: 10735930
[TBL] [Abstract][Full Text] [Related]
13. Liver biopsy in primary biliary cholangitis: is sinusoidal fibrosis the missing key?
Warnes T; Roberts S; Smith A; Haboubi N; McMahon RF
J Clin Pathol; 2019 Oct; 72(10):669-676. PubMed ID: 31371396
[TBL] [Abstract][Full Text] [Related]
14. RANK/RANKL Acts as a Protective Factor by Targeting Cholangiocytes in Primary Biliary Cholangitis.
Hao YL; Bian ZL; Ju LL; Liu Y; Qin G
Dig Dis Sci; 2020 Feb; 65(2):470-479. PubMed ID: 31377883
[TBL] [Abstract][Full Text] [Related]
15. The transferrin isoforms in chronic hepatitis.
Gruszewska E; Wrona A; Gudowska M; Panasiuk A; Cylwik B; Lipartowska-Klimuk K; Flisiak R; Chrostek L
Clin Biochem; 2017 Dec; 50(18):1131-1135. PubMed ID: 28673788
[TBL] [Abstract][Full Text] [Related]
16. [Primary biliary cholangitis and bile acid metabolism].
Wang L; Han YC; Han Y
Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):874-877. PubMed ID: 29325285
[TBL] [Abstract][Full Text] [Related]
17. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.
Trottier J; Białek A; Caron P; Straka RJ; Heathcote J; Milkiewicz P; Barbier O
Dig Liver Dis; 2012 Apr; 44(4):303-10. PubMed ID: 22169272
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of cholestatic liver disease].
Pleşa A
Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):733-6. PubMed ID: 14756010
[TBL] [Abstract][Full Text] [Related]
19. Concomitant nonalcoholic fatty liver disease does not alter the activity, severity or course of primary biliary cholangitis.
Minuk GY; Iliant V; Zhou N; Kaita KD; Wong SG; Peretz D; Uhanova J
Liver Int; 2018 Jun; 38(6):1110-1116. PubMed ID: 29193593
[TBL] [Abstract][Full Text] [Related]
20. [Cholestatic liver diseases].
Thimme R; Opitz OG; Blum HE; Kreisel W
Ther Umsch; 2004 Aug; 61(8):521-7. PubMed ID: 15457969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
